[Nicardipine attenuates the sympathetic reflex of orthostatism: do dihydropyridine-sensitive calcium channels regulate noradrenaline release?].
Twelve hypertensive subjects were treated for 2 weeks with the dihydropyridine calcium channel antagonist nicardipine (40 mg daily) according to a double-blind, placebo-controlled study protocol. Nicardipine treatment significantly decreased systolic and diastolic blood pressure and increased plasma noradrenaline levels measured at supine rest. However, the treatment significantly inhibited the physiological increase of circulating neurotransmitter following sympathetic stimulation induced by orthostatism. These results suggest that dihydropyridine-sensitive calcium channels may modulate the noradrenaline release from nerve terminals of the peripheral sympathetic nervous system.